Tuberculosis-induced variant IL-4 mRNA encodes a cytokine functioning as growth factor for (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-specific Vγ2Vδ2 T cells

Journal of Immunology

Volumn 182, Issue 2, 2009, Pages 811-819

  Yuan, ZhuQing ^a,b   Wang, Richard ^a   Lee, Yuyang ^a   Chen, Crystal Y ^a   Yu, XingBing ^b   Wu, ZhongDao ^b   Huang, Dan ^a   Shen, Ling ^c   Chen, Zheng W ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHYL BUT 2 ENYLPYROPHOSPHATE; ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; MESSENGER RNA; PROLINE; PYROPHOSPHORIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VARIANT INTERLEUKIN 4; 4 HYDROXY 3 METHYLBUT 2 ENYL PYROPHOSPHATE; 4-HYDROXY-3-METHYLBUT-2-ENYL PYROPHOSPHATE; INTERLEUKIN 4 VARIANT; INTERLEUKIN-4 VARIANT; LYMPHOCYTE ANTIGEN RECEPTOR; PYROPHOSPHATE; SIGNAL PEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BOVINE TUBERCULOSIS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EFFECTOR CELL; MACACA; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUBERCULOSIS; VGAMMA2VDELTA2 T LYMPHOCYTE; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; RNA SPLICING; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL PROLIFERATION; DIPHOSPHATES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MACACA FASCICULARIS; MACACA MULATTA; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RNA SPLICING; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS;

EID: 60549095318     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.2.811     Document Type: Article

References (56)

1. Ferrick, D. A., M. D. Schrenzel, T. Mulvania, B. Hsieh, W. G. Ferlin, and H. Lepper. 1995. Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γ δT cells in vivo. Nature 373: 255-257.
2. Brown, M. A., J. H. Pierce, C. J. Watson, J. Falco, J. N. Ihle, and W. E. Paul. 1987. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 50: 809-818.
3. MacGlashan, D., Jr., J. M. White, S. K. Huang, S. J. Ono, J. T. Schroeder, and L. M. Lichtenstein. 1994. Secretion of IL-4 from human basophils: the relationship between IL-4 mRNA and protein in resting and stimulated basophils. J. Immunol. 152: 3006-3016.
4. Paul, W. E. 1991. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77: 1859-1870.
5. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145: 3796-3806.
6. Sorg, R. V., J. Enczmann, U. R. Sorg, E. M. Schneider, and P. Wernet. 1993. Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2. Exp. Hematol. 21: 560-563.
7. Atamas, S. P., J. Choi, V. V. Yurovsky, and B. White. 1996. An alternative splice variant of human IL-4, IL-4 δ 2, inhibits IL-4-stimulated T cell proliferation. J. Immunol. 156: 435-441.
8. Alms, W. J., S. P. Atamas, V. V. Yurovsky, and B. White. 1996. Generation of a variant of human interleukin-4 by alternative splicing. Mol. Immunol. 33: 361-370.
9. Arinobu, Y., S. P. Atamas, T. Otsuka, H. Niiro, K. Yamaoka, H. Mitsuyasu, Y. Niho, N. Hamasaki, B. White, and K. Izuhara. 1999. Antagonistic effects of an alternative splice variant of human IL-4, IL-4δ2, on IL-4 activities in human monocytes and B cells. Cell. Immunol. 191: 161-167.
10. Eberl, M., M. Hintz, A. Reichenberg, A. K. Kollas, J. Wiesner, and H. Jomaa. 2003. Microbial isoprenoid biosynthesis and human γδ T cell activation. FEBS Lett. 544: 4-10.
11. Dieli, F., D. Vermijlen, F. Fulfaro, N. Caccamo, S. Meraviglia, G. Cicero, A. Roberts, S. Buccheri, M. D'Asaro, N. Gebbia, et al. 2007. Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res. 67: 7450-7457.
12. Beetz, S., L. Marischen, D. Kabelitz, and D. Wesch. 2007. Human γ δT cells: candidates for the development of immunotherapeutic strategies. Immunol. Res. 37: 97-111.
13. Hintz, M., A. Reichenberg, B. Altincicek, U. Bahr, R. M. Gschwind, A. K. Kollas, E. Beck, J. Wiesner, M. Eberl, and H. Jomaa. 2001. Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human γδ T cells in Escherichia coli. FEBS Lett. 509: 317-322.
14. Garcia, V. E., P. A. Sieling, J. Gong, P. F. Barnes, K. Uyemura, Y. Tanaka, B. R. Bloom, C. T. Morita, and R. L. Modlin. 1997. Single-cell cytokine analysis of γ δT cell responses to nonpeptide mycobacterial antigens. J. Immunol. 159: 1328-1335.
15. Altincicek, B., J. Moll, N. Campos, G. Foerster, E. Beck, J. F. Hoeffler, C. Grosdemange-Billiard, M. Rodriguez-Concepcion, M. Rohmer, A. Boronat, et al. 2001. Cutting edge: human γ δT cells are activated by intermediates of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis. J. Immunol. 166: 3655-3658.
16. Belmant, C., E. Espinosa, R. Poupot, M. A. Peyrat, M. Guiraud, Y. Poquet, M. Bonneville, and J. J. Fournie. 1999. 3-Formyl-1-butyl pyrophosphate A novel mycobacterial metabolite-activating human γδ T cells. J. Biol. Chem. 274: 32079-32084.
17. Kuzuyama, T. 2002. Mevalonate and nonmevalonate pathways for the biosynthesis of isoprene units. Biosci. Biotechnol. Biochem. 66: 1619-1627.
18. Wei, H., D. Huang, X. Lai, M. Chen, W. Zhong, R. Wang, and Z. W. Chen. 2008. Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3- methyl-but-2-enyl pyrophosphate to Vγ2Vδ2 TCR. J. Immunol. 181: 4798-4806.
19. Ali, Z., L. Shao, L. Halliday, A. Reichenberg, M. Hintz, H. Jomaa, and Z. W. Chen. 2007. Prolonged (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-driven antimicrobial and cytotoxic responses of pulmonary and systemic Vγ2Vδ2 T cells in macaques. J. Immunol. 179: 8287-8296.
20. Huang, D., Y. Shen, L. Qiu, C. Y. Chen, L. Shen, J. Estep, R. Hunt, D. Vasconcelos, G. Du, P. Aye, et al. 2008. Immune distribution and localization of phosphoantigen-specific Vγ2Vδ2 T cells in lymphoid and nonlymphoid tissues in Mycobacterium tuberculosis infection. Infect. Immun. 76: 426-436.
21. + T cells during mycobacterial infections. Science 295: 2255-2258.
22. Boullier, S., Y. Poquet, T. Debord, J. J. Fournie, and M. L. Gougeon. 1999. Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the Vγ9Vδ2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons. Eur. J. Immunol. 29: 90-99.
23. Vermijlen, D., P. Ellis, C. Langford, A. Klein, R. Engel, K. Willimann, H. Jomaa, A. C. Hayday, and M. Eberl. 2007. Distinct cytokine-driven responses of activated blood γδ T cells: insights into unconventional T cell pleiotropy. J. Immunol. 178: 4304-4314.
24. Qiu, L., D. Huang, C. Y. Chen, R. Wang, L. Shen, J. Estep, R. Hunt, N. L. Letvin, G. Du, and Z. W. Chen. 2008. Severe TB induced unbalanced gene networks, over-expressions of IL-22, MIP-1δ, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-β, Tim1, TLR2, but low cellular immune responses. J. Infect. Dis. 22: 2241-2250.
25. Shen, Y., L. Shen, P. Sehgal, D. Huang, L. Qiu, G. Du, N. L. Letvin, and Z. W. Chen. 2004. Clinical latency and reactivation of AIDS-related mycobacterial infections. J. Virol. 78: 14023-14032.
26. + T-cell responses during active mycobacterial coinfection of simian immunodeficiency virus SIV-mac-infected monkeys. J. Virol. 77: 2998-3006.
27. Huang, D., L. Qiu, R. Wang, X. Lai, G. Du, P. Seghal, Y. Shen, L. Shao, L. Halliday, J. Fortman, et al. 2007. Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity. J. Infect. Dis. 195: 55-69.
28. Villinger, F., S. S. Brar, A. Mayne, N. Chikkala, and A. A. Ansari. 1995. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J. Immunol. 155: 3946-3954.
29. Watanabe, S., M. Kondo, K. Takatsu, K. Sugamura, and K. Arai. 1995. Involvement of the interleukin-2 receptor γ subunit in interleukin-4-dependent activation of mouse hematopoietic cells and splenic B cells. Eur. J. Immunol. 25: 126-131.
30. Kruse, N., T. Lehrnbecher, and W. Sebald. 1991. Site-directed mutagenesis reveals the importance of disulfide bridges and aromatic residues for structure and proliferative activity of human interleukin-4. FEBS Lett. 286: 58-60.
31. Ceroni, A., A. Passerini, A. Vullo, and P. Frasconi. 2006. DISULFIND: a disulfide bonding state and cysteine connectivity prediction server. Nucleic Acids Res. 34: W177-W181.
32. Ohara, J., J. E. Coligan, K. Zoon, W. L. Maloy, and W. E. Paul. 1987. High-efficiency purification and chemical characterization of B cell stimulatory factor-1/interleukin 4. J. Immunol. 139: 1127-1134.
33. Le, H. V., L. Ramanathan, J. E. Labdon, C. A. Mays-Ichinco, R. Syto, N. Arai, P. Hoy, Y. Takebe, T. L. Nagabhushan, and P. P. Trotta. 1988. Isolation and characterization of multiple variants of recombinant human interleukin 4 expressed in mammalian cells. J. Biol. Chem. 263: 10817-10823.
34. van Kimmenade, A., M. W. Bond, J. H. Schumacher, C. Laquoi, and R. A. Kastelein. 1988. Expression, renaturation and purification of recombinant human interleukin 4 from Escherichia coli. Eur J. Biochem. 173: 109-114.
35. Green, M. R. 1986. Pre-mRNA splicing. Annu. Rev. Genet. 20: 671-708.
36. Tsytsikov, V. N., V. V. Yurovsky, S. P. Atamas, W. J. Alms, and B. White. 1996. Identification and characterization of two alternative splice variants of human interleukin-2. J. Biol. Chem. 271: 23055-23060.
37. Kestler, D. P., S. Agarwal, J. Cobb, K. M. Goldstein, and R. E. Hall. 1995. Detection and analysis of an alternatively spliced isoform of interleukin-6 mRNA in peripheral blood mononuclear cells. Blood 86: 4559-4567.
38. Korte, A., A. Moricke, B. Beyermann, J. Kochling, T. Taube, C. Kebelmann-Betzing, G. Henze, and K. Seeger. 1999. Extensive alternative splicing of interleukin-7 in malignant hematopoietic cells: implication of distinct isoforms in modulating IL-7 activity. J. Interferon. Cytokine Res. 19: 495-503.
39. Anderson, D. M., S. D. Lyman, A. Baird, J. M. Wignall, J. Eisenman, C. Rauch, C. J. March, H. S. Boswell, S. D. Gimpel, D. Cosman, et al. 1990. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63: 235-243.
40. Gautherot, I., N. Burdin, D. Seguin, L. Aujame, and R. Sodoyer. 2002. Cloning of interleukin-4 δ2 splice variant (IL-4δ2) in chimpanzee and cynomolgus macaque: phylogenetic analysis of δ2 splice variant appearance, and implications for the study of IL-4-driven immune processes. Immunogenetics 54: 635-644.
41. Perkins, H. D., B. H. van Leeuwen, C. M. Hardy, and P. J. Kerr. 2000. The complete cDNA sequences of IL-2, IL-4, IL-6 and IL-10 from the European rabbit (Oryctolagus cuniculus). Cytokine 12: 555-565.
42. Yatsenko, O. P., M. L. Filipenko, E. A. Khrapov, E. N. Voronina, V. A. Kozlov, and S. V. Sennikov. 2004. Alternative splicing of mRNA of mouse interleukin-4 and interleukin-6. Cytokine 28: 190-196.
43. Waldvogel, A. S., M. F. Lepage, A. Zakher, M. P. Reichel, R. Eicher, and V. T. Heussler. 2004. Expression of interleukin 4, interleukin 4 splice variants and interferon γ mRNA in calves experimentally infected with Fasciola hepatica. Vet. Immunol. Immunopathol. 97: 53-63.
44. Rhodes, S. G., J. Sawyer, A. O. Whelan, G. S. Dean, M. Coad, K. J. Ewer, A. S. Waldvogel, A. Zakher, D. J. Clifford, R. G. Hewinson, and H. M. Vordermeier. 2007. Is interleukin-4δ3 splice variant expression in bovine tuberculosis a marker of protective immunity? Infect. Immun. 75: 3006-3013.
45. Pawson, T., and J. D. Scott. 1997. Signaling through scaffold, anchoring, and adaptor proteins. Science 278: 2075-2080.
46. Zarrinpar, A., R. P. Bhattacharyya, and W. A. Lim. 2003. The structure and function of proline recognition domains. Sci. STKE 2003: RE8.
47. Mayer, B. J. 2001. SH3 domains: complexity in moderation. J. Cell Sci. 114: 1253-1263.
48. Kay, B. K., M. P. Williamson, and M. Sudol. 2000. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14: 231-241.
49. Brenner, M. B., J. McLean, D. P. Dialynas, J. L. Strominger, J. A. Smith, F. L. Owen, J. G. Seidman, S. Ip, F. Rosen, and M. S. Krangel. 1986. Identification of a putative second T-cell receptor. Nature 322: 145-149.
50. Carr, C., S. Aykent, N. M. Kimack, and A. D. Levine. 1991. Disulfide assignments in recombinant mouse and human interleukin 4. Biochemistry 30: 1515-1523.
51. Vaz, D. C., J. R. Rodrigues, W. Sebald, C. M. Dobson, and R. M. Brito. 2006. Enthalpic and entropic contributions mediate the role of disulfide bonds on the conformational stability of interleukin-4. Protein Sci. 15: 33-44.
52. Kruse, N., B. J. Shen, S. Arnold, H. P. Tony, T. Muller, and W. Sebald. 1993. Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. EMBO J. 12: 5121-5129.
53. Wang, L., H. Das, A. Kamath, and J. F. Bukowski. 2001. Human V γ 2V δ 2 T cells produce IFN-γ and TNF-α with an on/off/on cycling pattern in response to live bacterial products. J. Immunol. 167: 6195-6201.
54. Schnarr, B., J. Ezernieks, W. Sebald, and A. Duschl. 1997. IL-4 receptor complexes containing or lacking the γ C chain are inhibited by an overlapping set of antagonistic IL-4 mutant proteins. Int. Immunol. 9: 861-868.
55. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254.
56. Andersen, P. 1997. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand. J. Immunol. 45: 115-131.